Position in BLTE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$487,473,769
+$3,162,238 QoQ
Shares Held
3,057,412
+1.0% QoQ
Ownership
7.63%
of shares outstanding
% of Portfolio
12.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BLTE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Darwin Global Management, Ltd. holds $4,026,455,721 across 6 Biotechnology names. BLTE ranks #2 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
16,805,184 | $2,747,983,687 | |
| 2 | BLTE |
Belite Bio, Inc
This page
|
3,057,412 | $487,473,769 | |
| 3 | ABVX |
Abivax S.A.
|
3,468,657 | $386,234,956 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
2,211,018 | $215,021,500 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
6,797,300 | $188,285,210 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
17,357 | $1,456,599 |
All Filings in BLTE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $487,473,769 | 3,057,412 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $484,311,531 | 3,027,704 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $484,311,531 | 3,027,704 | Shares | Sole | 2026-02-17 | |
| 2025-12-03 | $397,248,698 | 2,617,094 | Shares | Sole | 2025-12-10 | |
| No filing history on record for this holder in this stock. | ||||||